Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2/3 1Phase 2 1

Status

Completed 2

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Hodgkin Disease 21Lymphoma 13Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Urinary Bladder Neoplasms 5Testicular Neoplasms 3Prostatic Neoplasms 3Melanoma 3Urethral Neoplasms 2Testicular Germ Cell Tumor 2Teratoma 2Lymphoma, Large-Cell, Anaplastic 2Uterine Cervical Neoplasms 1Skin Neoplasms 1Seminoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Lymphoma, Large B-Cell, Diffuse 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Leukemia 1Endodermal Sinus Tumor 1Carcinoma, Embryonal 1Adenocarcinoma of Lung 1

Interventions

Cisplatin 4Paclitaxel 3Vinblastine 2Methotrexate 2Gemcitabine 2Doxorubicin 2Carboplatin 2cabozantinib 1avelumab 1Specimen Handling 1Ramucirumab 1Platinum 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Fentanyl 1Docetaxel 1Disulfides 1Bevacizumab 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Urethral Neoplasms × Vinblastine × Clear all
NCT00003376 2023-06-22

Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium

Eastern Cooperative Oncology Group

Phase 3 Completed
330 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00003701 2023-06-15

Combination Chemotherapy in Treating Patients With Bladder Cancer

Eastern Cooperative Oncology Group

Phase 3 Completed
490 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡